Which stock wins in a battle between these pharmacy giants?
News & Analysis: CVS Health
The drug store chain just hired an executive from Fitbit as it tries to expand beyond pharmacies and consumer product sales.
Investors need to be careful about which pharmaceutical stocks they own.
High yields. Low valuations. But with a couple of downsides to be aware of.
Despite rapidly changing dynamics in the pharmaceutical industry, CVS Health looks like the clear leader.
For a few companies, the second half of 2019 will probably work out better than investors dared hope for earlier this year.
CVS earnings call for the period ending June 30, 2019.
The big healthcare company beat its earnings guidance with help from Aetna, higher brand drug prices, and a shift in the Easter holiday.
Wednesday morning brought selling for the stock market.
Better-than-expected Q2 results are making investors happy.